Evaluation of human cystic echinococcosis before and after surgery and chemotherapy by demonstration of antibodies in serum

• Autorzy: Tenguria R.K. , Naik M. I.
• Języki publikacji: EN

Abstrakty

EN

Human cystic echinococcosis (CE), caused by Echinococcus granulosus, is one of the most important and widespread parasitic zoonoses. As one of the problems that can be encountered after treating CE patients is the risk of postsurgical relapses or treatment failure, a long-term clinical and serological follow-up is required to evaluate the success and failure of therapy. Therefore, the aim of the present study was to identify the best diagnostic and prognostic ELISA markers in patients with CE. The cohort comprised 50 patients with symptomatic CE treated with antihelminthic drugs and surgery, who were followed up clinically and radiologically for a mean of 6 years (range 4–8 years). The results clearly indicate that the hydatid specific antibodies of IgE, IgG1 and IgG4 are the most important antibodies for the serological diagnosis of cystic echinococcosis during the active stage of the disease. None of the serum samples from healthy controls gave a non-specific reaction with IgE, IgG1 or IgG4, and a considerably reduced cross-reaction was observed with these antibodies. During post-operative follow-up, the IgM, IgE, IgG1, IgG2 and IgG4 antibody response provided the best correlate of disease activity. The detection of total IgG and IgG3 subclass antibody response for the assessment of post-treatment disease activity among CE patients was insensitive. All patients responded to treatment except 2 women (32 and 36 years old), in whom multiple cysts (12 and 7 cysts) were detected in the liver and lung two years after the first operation. Hence, it can be concluded that the CE-specific antibodies of IgE, IgG1 and IgG4 are the best immunological markers for diagnosis and prognosis of CE patients.

Słowa kluczowe

EN

human disease; cystic echinococcosis; echinococcosis; surgery; chemotherapy; antibody; immunodiagnosis; ELISA test

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2014
• Tom: 60
• Numer: 4
• Opis fizyczny: p.297-303,ref.

Twórcy

autor

Tenguria R.K.

• Department of Microbiology, Govt.Motilal Vigyan Mahavidyalya, Bhopal-Madhya Pradesh, 462 008 India

autor

Naik M. I.

• Department of Microbiology, Govt.Motilal Vigyan Mahavidyalya, Bhopal-Madhya Pradesh, 462 008 India

Bibliografia

• [1] Babba H., Messedi A., Masmoudi S., Zribi M., Grillot R., Ambriose-Thomas P., Beyrouti I., Sahnoun Y. 1994. Diagnosis of human hydatidosis: comparison between imagery and six serologic techniques. The American Journal of Tropical Medicine and Hygiene 50: 64-68.
• [2] Gottstein B., Reichen J. 2003. Echino co ccosis/hydatidosis. In: Manson’s Tropical Diseases. (Eds. G.C. Cook, A. Zumla). London, W.B. Saunders, Elsevier Science Ltd: 1561-1582.
• [3] Eckert J., Schantz P.M., Gasser R.P., Torgerson P.R., Bessonov A.S., Movsessian S.O., Thakur A., Grimm F., Nikogossian M.A. 2001. Geographic distribution and prevalence. In: Manual on Echinococcosis in humans and animals: a public health problem of global concern. (Eds. J. Eckert, M.A. Gemmell, F.X. Meslin, Z.S. Pawłowski). WHO/OIE, Paris, France: 100-142.
• [4] World Health Organization (W.H.O) Informal Working Group. 2003. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Tropica 85: 253-261.
• [5] Wen H., New R.R., Craig P.S. 1993. Diagnosis and treatment of human hydatidosis. British Journal of Clinical Pharmacology 35: 565-574.
• [6] WHO-IWGE 1996. Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bulletin WHO 76: 231-242.
• [7] Wattal C., Malla N., Khan I.A., Agarwal S.C. 1986. Comparative evaluation of enzyme-linked immunosorbent assay for the diagnosis of pulmonary echinococcosis. Journal of Clinical Microbiology 21: 41-46.
• [8] Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. 1951. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193: 265-275.
• [9] Lawn S.D., Bligh J., Craig P.S., Chiodini P.L. 2004. Human cystic echinococcosis: Evaluation of post treatment serologic follow-up by IgG subclass antibody detection. The American Journal of Tropical Medicine and Hygiene 70: 329-335.
• [10] Zhang W., Li J., McManus D.P. 2003. Concepts in immunology and diagnosis of hydatid disease. Clinical Microbiology Reviews 16: 18-36.
• [11] Chirag S., Fomda B.A., Khan A., Malik A.A., Lone G.N., Khan B.A., Zahoor D. 2014. Detection of hydatid specific antibodies in the serum and urine for the diagnosis of cystic echinococcosis in patients from the Kashmir Valley, India. Helminthology 16: 1-6.
• [12] Shambesh M.K., Craig P.S., Wen H., Rogan M.T., Paolillo E. 1997. IgG1 and IgG4 serum antibody responses in asymptomatic and clinically expressed cystic echinococcosis patients. Acta Tropica 64: 53-63.
• [13] Sterla S., Sato H., Nieto A. 1999. E. granulosus human infection stimulates low avidity anticarbohydrate IgG2 and high avidity antipeptide IgG4 antibodies. Parasite Immunology 21: 27-34.
• [14] Zhang W., Ross A.G., McManus D.P. 2008. Mechanisms of immunity in hydatid disease: implications for vaccine development. Journal of Immunology 181: 6679-6685.
• [15] Wen H.,Craig P.S.1994. Immunoglobulin G subclass responses in human cystic and alveolar echinococcosis. The American Journal of Tropical Medicine and Hygiene 51: 741-748.
• [16] Virginio V.G., Hernández A., Rott M.B., Monteiro K.M., Zandonai A.F., Nieto A., Zaha A., Ferreira H.B. 2003. A set of recombinant antigens from Echinococcus granulosus with potential for use in the immunodiagnosis of human cystic hydatid disease. Clinical and Experimental Immunology 132: 309-315.
• [17] Felix G., Friedrich E.M., Jian L., Roberto L. 1998. Analysis of specific immunoglobulin G subclass antibodies for serological diagnosis of echinococcosis by a standard enzyme-linked immunosorbent Assay. Clinical and Diagnostic Laboratory Immunology 5: 613-616.
• [18] Khabiri A.R., Bagheri F., Assmar M., Siavashi M.R. 2006. Analysis of specific IgE and IgG subclass antibodies for diagnosis of Echinococcus granulosus. Parasite Immunology 28: 357-362.
• [19] Rigano R., Profumo E., Ioppolo S., Notargiacomo S., Ortona E., Teggi A., Siracusano A. 1995. Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease. Clinical and Experimental Immunology 102: 281-285.
• [20] Vedat B., Falya I., Ahmet Yasar Y., Suleyman O., Yavuz I., Ahmet G. 2001. Immunological follow up of hydatid cyst cases. Memórias do Instituto Oswaldo Cruz 96: 669-671.
• [21] Doiz B.R., Benito R., Gil J., Rojar A., Rubio M.C., Ossuma A. 2002. Pre and postsurgical detection of IgG, IgM and IgA specific to hydatidosis by ELISA with purified antigen enriched with 5/B antigen complex. Journal of Clinical Laboratory Analysis 16: 295-298.
• [22] Zarzosa M.P., Orduna A., Gutierrez P., Alonso P., Cuervo M., Prado A.M., Bratos A., Garcia-Yuste M., Ramos G., Torres A. 1999. Evaluation of six serological tests in diagnosis and postoperative control of pulmonary hydatid disease patients. Diagnostic Microbiology and Infectious Disease 35: 255-262.
• [23] Daeki A.O., Craig P.S., Shambash M.K. 2000. IgGsubclass antibody responses and the natural history of hepatic Cystic Echinococcosis in asymptomatic patients. Annals of Tropical Medicine and Parasitology 94: 319-328.
• [24] Rigano R., Buttari B., Profumo E., Ortona E., Margutti P., Teggi A., Siracusano A. 2002. Apopoptosis modulation in PMBC from patients with cystic echinococcosis. The American Journal of Tropical Medicine and Hygiene 67: 298-299.
• [25] Guerri M.L., Davila M., Rodriguez M., Javier Nieto F., Ladron de Guevara C. 2000. Utility of IgG subclasses in the diagnosis and follow-up of hydatidosis. Enfermedades Infecciosas y Micro biologia Clinica 18: 262-266.
• [26] Elsebaie S.B., El-Sebae M.M., Esmat M.E., Nasr M.M., Kamel M.M. 2006. Modified endocystectomy versus pericystectomy in Echinococcus granulosus liver cysts: a randomized controlled study, and the role of specific antihydatid IgG4 in detection of early recurrence. Journal of the Egyptian Society of Parasitology 36: 993-1006.
• [27] Michael D., Rickard R.D., Honey J.L., Brumley L., Mitchell G.F. 1984. Serological diagnosis and post operative surveillance of human hydatid disease II. The Enzyme Linked Immunosorbent Assay (ELISA) using various antigens. Pathology 16: 211-215.
• [28] Wang Y., He T., Wen X., Li T., Waili A., Zhang W., Xu X., Vuitton D.A., Rogan M.T., Wen H., Craig P.S. 2006. Post survey follow up for human cystic echinococcosis in Northwest China. Acta Tropica 98: 43-51.
• [29] Poretti D., Felleisen E., Grimm F., Pfister M., Teuscher F., Zuercher C., Reichen J. Gottstein B. 1999. Differential Immunodiagnosis between cystic hydatid disease and other cross reactive pathologies. The American Journal of Tropical Medicine and Hygiene 60: 193-198.
• [30] Sunita T., Dubey M.L., Khurana S., Malla N. 2007. Specific antibody detection in urine, serum and saliva samples for the diagnosis of cystic echinococcosis. Acta Tropica 101: 187-191.